Platelet predominant breast cancer is a new predictor for pathological complete response to neoadjuvant chemotherapy

被引：0
|
作者：
Ishikawa, Satoko [1 ]
Inokuchi, Masafumi [1 ]
Hayashi, Hironori [1 ]
Oyama, Katsunobu [1 ]
Nakagawara, Hisatoshi [1 ]
Miyashita, Tomoharu [1 ]
Tajima, Hidehiro [1 ]
Takamura, Hiroyuki [1 ]
Ninomiya, Itasu [1 ]
Kitagawa, Hirohisa [1 ]
Fushida, Sachio [1 ]
Fujimura, Takashi [1 ]
Ohta, Tetsuo [1 ]
机构：
[1] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-34
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian
    Krishnamurti, Uma
    Bhattarai, Shristi
    Klimov, Sergey
    Reid, Michelle
    Aneja, Ritu
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 54A - 54A
  • [2] Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian
    Krishnamurti, Uma
    Bhattarai, Shristi
    Klimov, Sergey
    Reid, Michelle
    Aneja, Ritu
    [J]. MODERN PATHOLOGY, 2016, 29 : 54A - 54A
  • [3] Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer
    Takaoka, Megumi
    Ohsumi, Shozo
    Ikejiri, Haruka
    Shidahara, Tomohiro
    Miyoshi, Yuichiro
    Takahashi, Mina
    Takashima, Seiki
    Aogi, Kenjiro
    [J]. ACTA MEDICA OKAYAMA, 2022, 76 (02) : 105 - 111
  • [4] Pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
    Montemurro, Filippo
    Di Cosimo, Serena
    [J]. BREAST, 2014, 23 (05): : 690 - 691
  • [5] A predictor of pathological complete response to neoadjuvant chemotherapy in triple -negative breast cancer patients with the DNA repair genes
    Huang, Liang
    Lang, Guan-Tian
    Liu, Qi
    Shi, Jin-Xiu
    Shao, Zhi-Ming
    Cao, A-Yong
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (04)
  • [6] Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer
    Ishikawa, Takashi
    Shimizu, Daisuke
    Sasaki, Takashi
    Morita, Satoshi
    Tanabe, Mikiko
    Ota, Ikuko
    Kawachi, Kae
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Improving pathological complete response in luminal breast cancer after neoadjuvant chemotherapy
    Cudos, Ariadna Gasol
    Murillo, Serafin Morales
    Galindo, Alvaro Rodriguez
    Subirats, Ona Pallise
    Olive, Jordi Mele
    Morales, Carles Canosa
    Villellas, Felip Vilardell
    Guzman, Douglas Rene Sanchez
    Rodriguez, Joel Veas
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [8] Factors predicting a pathological complete response following neoadjuvant chemotherapy for breast cancer
    Choi, H.
    Van Belle, V.
    Wildiers, H.
    Paridaens, R.
    Amant, F.
    Van Limbergen, E.
    Moerman, P.
    Smeets, A.
    Vergote, I.
    Neven, P.
    [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 66 - 67
  • [9] Demographic determinants of pathological complete response after neoadjuvant chemotherapy in breast cancer
    Dharanikota, A.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
  • [10] Pathological complete response (pCR) after neoadjuvant chemotherapy in luminal breast cancer
    Cordoba Ortega, J. F.
    Gasol Cudos, A.
    Morales Murillo, S.
    Vilardell Villellas, F.
    Siso Raber, C.
    Canosa Morales, C.
    Salud Salvia, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S313 - S313
12345